Open AccessPharmacotherapy and Pregnancy: Highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy
Author(s) -
Haas David M.,
Gallauresi Beverly,
Shields Kristine,
Zeitlin Deborah,
Clark Shan M.,
Hebert Mary F.,
Ren Zhaoxia,
Nallani Srikanth C.,
Meslin Eric M.,
Feibus Karen B.,
Koren Gideon,
Goebel W. Scott,
Easterling Thomas,
Denne Scott C.,
Flockhart David A.,
Renbarger Jamie L.
Publication year - 2011
Publication title -
clinical and translational science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 44
eISSN - 1752-8062
pISSN - 1752-8054
DOI - 10.1111/j.1752-8062.2011.00280.x
Subject(s) - pregnancy , pharmacotherapy , medicine , intensive care medicine , medline , psychiatry , genetics , biology , political science , law
To address provider struggles to provide evidence‐based, rational drug therapy to pregnant women, this third Conference was convened to highlight the current progress and research in the field. Speakers from academic centers, industry, and governmental institutions spoke about: the Food and Drug Administration’s role in pregnancy pharmacology and the new labeling initiative; drug registries in pregnancy; the pharmacist’s role in medication use in pregnancy; therapeutic areas such as preterm labor, gestational diabetes, nausea and vomiting in pregnancy, and hypertension; breast‐feeding and medications; ethical challenges for consent in pregnancy drug studies; the potential for cord blood banks; and concerns about the fetus when studying drugs in pregnancy. The Conference highlighted several areas of collaboration within the current Obstetrics Pharmacology Research Units Network and hoped to educate providers, researchers, and agencies with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy. Clin Trans Sci 2011; Volume 4: 204–209